Acute Stroke
Conditions
Keywords
tissue plasminogen activator, acute stroke, intravenous tissue plasminogen activator, nursing care, neurology nursing, acute stroke treatment
Brief summary
Intravenous (IV) tissue plasminogen activator (tPA) is one of the key elements of acute ischemic stroke. In this study, acute stroke patients maximum benefit from the treatment, intravenous tissue plasminogen activator (IV tPA) minimizing the errors related to the treatment of acute ischemic stroke patients of nursing students from clinical practice guides published on the treatment of It is aimed to be informed and to standardize nursing interventions.
Detailed description
Time management in acute stroke patients is possible with a multidisciplinary approach and team members who have received specific training for acute stroke patients. Studies have shown that the maximum result of treatment for acute stroke patients depends on nurses' ability to identify disease symptoms, plan and apply symptom-specific nursing care. There is evidence that the multidisciplinary presence of stroke teams in stroke units and the delivery of coordinated care during the acute phase improve patient outcomes . Coordinated care by the stroke team improves patient outcomes, reduces hospital costs, reduces patient readmission, and improves patient care quality.
Interventions
BEHAVIORALtheory training
theory training
BEHAVIORALtheory and simulation training
theory and simulation training
Sponsors
Dokuz Eylul University
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Masking description
Intern nurses will be numbered from 1 to 75 and will be randomly divided into study and control groups from the random numbers table. After the groups are determined by the randomization method, each intern nurse in the study and control groups will be interviewed face to face and their written informed consent will be obtained. Then, all nursing intern students participating in the research will be asked to fill in the IV tPA Treatment Knowledge Level Evaluation Form, Self-Efficacy Competence Scale. Intern nurses in both groups will be given 1-hour theoretical training on IV tPA treatment before, during and after the procedure. In addition, simulation-based training will be applied to the intern nurses in the study group regarding IV tPA treatment before, during and after the procedure.
Intervention model description
Intern nurses will be numbered from 1 to 75 and will be randomly divided into study and control groups from the random numbers table. After the groups are determined by the randomization method, each intern nurse in the study and control groups will be interviewed face to face and their written informed consent will be obtained. Then, all nursing intern students participating in the research will be asked to fill in the IV tPA Treatment Knowledge Level Evaluation Form, Self-Efficacy Competence Scale. Intern nurses in both groups will be given 1-hour theoretical training on IV tPA treatment before, during and after the procedure. In addition, simulation-based training will be applied to the intern nurses in the study group regarding IV tPA treatment before, during and after the procedure.
Eligibility
Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
No
Inclusion criteria
Intern nursing student at Dokuz Eylül University
Exclusion criteria
Those who did not agree to participate in the study Those who were not be intern
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| self-efficacy scale | Change from baseline in Intravenous Tissue Plasminogen Activator Treatment knowledge and 2 weeks after intervention | Effectiveness change of Intravenous tissue plasminogen activator treatment knowledge after theoric teaching |
| simulation scale | 2 weeks after simulation training | evaluation the simulation design |
| tPA treatment information form | Change from baseline in Intravenous Tissue Plasminogen Activator Treatment knowledge and 2 weeks after intervention | Effectiveness change of Intravenous tissue plasminogen activator treatment knowledge after simulation and theoric teaching |
Countries
Turkey (Türkiye)
Outcome results
None listed